ロード中...
Safety and efficacy of entecavir for the treatment of chronic hepatitis B
Entecavir is a cyclopentyl deoxyguanosine analog that was approved for the treatment of the hepatitis B virus (HBV) in 2005. In Phase III trials, it showed potent HBV suppression with drops of 6- to 7-log copies/mL in HBV DNA at 1 year. In addition, rates of genotypic resistance in nucleos(t)ide-naï...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3108748/ https://ncbi.nlm.nih.gov/pubmed/21694909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S4188 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|